LSPR‐Based Biosensing Enables the Detection of Antimicrobial Resistance Genes
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
The development of rapid, simple, and accurate bioassays for the detection of nucleic acids has received increasing demand in recent years. Here, localized surface plasmon resonance (LSPR) spectroscopy for the detection of an antimicrobial resistance gene, sulfhydryl variable β-lactamase (blaSHV), which confers resistance against a broad spectrum of β-lactam antibiotics is used. By performing limit of detection experiments, a 23 nucleotide (nt) long deoxyribonucleic acid (DNA) sequence down to 25 nm was detected, whereby the signal intensity is inversely correlated with sequence length (23, 43, 63, and 100 nt). In addition to endpoint measurements of hybridization events, the setup also allowed to monitor the hybridization events in real-time, and consequently enabled to extract kinetic parameters of the studied binding reaction. Performing LSPR measurements using single nucleotide polymorphism (SNP) variants of blaSHV revealed that these sequences can be distinguished from the fully complementary sequence. The possibility to distinguish such sequences is of utmost importance in clinical environments, as it allows to identify mutations essential for enzyme function and thus, is crucial for the correct treatment with antibiotics. Taken together, this system provides a robust, label-free, and cost-efficient analytical tool for the detection of nucleic acids and will enable the surveillance of antimicrobial resistance determinants.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- LSPR‐Based Biosensing Enables the Detection of Antimicrobial Resistance Genes
- Date Crossref
- 24/04/2023
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Leibniz Institute of Photonic Technology Department of Nanobiophotonics pays non établi dans la noticeStructure de recherche
-
Jena University Hospital Institute for Infectious Diseases and Infection Control pays non établi dans la noticeÉtablissement de santé
Department of Nanobiophotonics — Leibniz Institute of Photonic Technology et Institute for Infectious Diseases and Infection Control — Jena University Hospital.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.